Phase I/II randomized, double-masked, placebo-controlled study of processed amniotic fluid drops after PRK

PURPOSE

To evaluate the safety and efficacy of processed amniotic fluid (pAF) used postoperatively after photorefractive keratectomy (PRK).

SETTING

University of Utah, Moran Eye Center, Salt Lake City, Utah.

DESIGN

Randomized, double-masked, placebo-controlled prospective study.

METHODS

61 participants were randomized to receive either placebo or pAF drops, which were instilled 4 times per day for 1 week after PRK along with routine postoperative medications. The primary outcome measure was time to full re-epithelialization in days. Secondary measures included visual acuity at 30 days and postoperative pain scores during the first week.

RESULTS

There was no significant difference in time to re-epithelialization, with a median of 5 days for both groups. There were no difference in pain indicator scores during the first week and no difference in corneal staining scores at day 30 between the 2 groups. There were no adverse events.

CONCLUSIONS

This pilot study evaluating the safety and efficacy of pAF as an additional postoperative topical medication for PRK demonstrated that pAF did not improve the rate of epithelial healing after PRK. pAF may be safely studied in other ocular conditions to determine its effect on epithelial healing.

Refractive versus Corneal Changes After Photorefracive Keratectomy for Astigmatism

PURPOSE

To define measures of assessing success and subsequent ways to improve excimer laser treatment of astigmatism.

METHODS

We studied 97 eyes of 79 patients, followed for 12 months, that underwent photorefractive keratectomy (PRK) for myopia and astigmatism with a VISX 20/20 excimer laser. Preoperative spherical equivalent refraction at the corneal plane was between -1.00 and -15.00 D. Mean preoperative refractive astigmatism at the spectacle plan was -2.17 +/- 1.05 D (range, -1.25 to -6.00 D), which is -1.81 +/- 0.86 D (range -1.04 to -4.97 D) when calculated at the corneal plane. All patients were examined before and after surgery; examination included refraction, keratometry, and topography measurement.

RESULTS

The success in treatment of astigmatism appeared measurably less than the treatment of sphere when analogous indices were used for assessment. Success in astigmatism surgery improved, as measured by all parameters, after an additional 20% was applied to astigmatism treatment magnitude indicated by the VISX computer algorithm. The sequential modes of treatment undercorrected astigmatism magnitude to a greater extent than elliptical, but equivalent success rates were present in view of the greater astigmatic changes attempted using the sequential mode. The elliptical mode tended to produce a greater undercorrection of associated sphere (p = 0.313). Results measured by refraction showed a larger change than those measured by topography and keratometry.

CONCLUSION

During PRK with the VISX 20/20 laser, adjustment for undercorrection of astigmatism treatment achieves a fuller correction of astigmatism. When measuring astigmatic changes, results are different when comparing refractive astigmatism changes with corneal astigmatism changes measured by keratometry and topography.

Photorefractive Keratectomy for Compound Myopic Astigmatism With an Eye Cup Erodible Mask Delivery System

BACKGROUND

The erodible mask is a new energy delivery system for the 193-nm argon fluoride excimer laser. It consists of a polymethyl-methacrylate button, whose profile is transferred by photoablation onto the corneal surface. We present the 6- and 12-month results of this technique in the correction of compound myopic astigmatism.

METHODS

We performed the mask procedure on 21 eyes of 16 subjects (mean age, 30.7 years; range, 24 to 46) to correct combined myopia and astigmatism. Attempted myopic correction ranged between -1.50 diopters (D) and -10.00 D (mean, -7.07 D). Attempted astigmatic correction ranged between -1.50 D and -4.00 D (mean, -2.46 D).

RESULTS

Mean procedure error was: sphere +0.74 D (range, -3.00/+5.00), cylinder -1.41 D (range, -3.50/0.00) at 1 month after surgery; sphere +0.18 D (range, -2.50/+ 3.50), cylinder -1.56 D (range, -4.00/0.00) at 6 months; and sphere -1.30 D (range, -3.00/0.00), cylinder was -1.25 D (range, -2.00/-0.50) at 12 months (10 eyes). During follow up, haze values were never higher than 1, except for one case of haze 2 that regressed to 0 during follow up. Postoperative uncorrected visual acuity improved in all eyes where emmetropia was envisaged; none of the eyes lost spectacle-corrected visual acuity lines 6 or 12 months after surgery.

CONCLUSIONS

The erodible mask proved effective and fairly predictable mainly in the correction of the spherical component of refractive error, while the correction of astigmatism revealed greater unpredictability, with a constant trend to undercorrection.

Holmium: YAG Laser to Treat Astigmatism Associated With Myopia or Hyperopia

The Summit Technology, Inc. (Waltham, Mass.) holmium:YAG laser was used to treat astigmatism in 31 myopic and 8 hyperopic eyes. There was slow but continuing regression of effect even 1 year after treatment. This regression was particularly seen in hyperopic astigmatism, larger amounts of myopic astigmatism, and younger patients. In some cases keratometry readings returned to their pretreatment values. Males and females had similar results. The mean myopic shift in 9 myopic astigmatism eyes at 9-month follow up was 1 D.